Target intelligence / Profile preview

Family with sequence similarity 99 member B (FAM99B)

Target
FAM99B
Molecular classification
Long non-coding RNA (lncRNA), Non-protein coding gene, Intronic sense ncRNA
01

Overview

Family with sequence similarity 99 member B (FAM99B) is a liver-specific long non-coding RNA (lncRNA), highly expressed in hepatic tissue and markedly downregulated in hepatocellular carcinoma (HCC)[2][3][4][7]. FAM99B acts as a tumor suppressor, influencing cell proliferation, migration, invasion, and metabolic pathways associated with cancer progression[2][3][4]. Its decreased expression correlates with increased HCC malignancy and poor prognosis, making it a promising biomarker for diagnosis and prediction of HCC outcomes[2]. FAM99B does not encode a protein and is not a pharmacological target but may provide mechanistic and diagnostic insights into liver cancer biology[1][2][7].

Other names
FAM99BDKFZp781M09150Family with sequence similarity 99 member B (non-protein coding)Multiple previous identifiers (e.g., GC00U921691, ENSG00000205865, NCBI Gene: 100132464)
02

Biological functions

Tumor suppression in hepatocellular carcinoma (HCC)Regulation of cell proliferation, migration, invasionPossible involvement in metabolic and blood coagulation pathwaysRegulating cell cycle, apoptosis, metastasis, extracellular matrix remodeling, and metabolic reprogramming
03

Disease associations

Cancer (especially liver cancer / HCC)
04

Biomarkers

Prognostic biomarker for HCC (low expression associated with poor prognosis, vascular invasion, metastasis, advanced grade)Diagnostic auxiliary biomarker for HCC, with reported sensitivity and specificity comparable to AFP

Beyond the preview

Go deeper on Family with sequence similarity 99 member B (FAM99B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 99 member B (FAM99B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call